ALPA vs THEMISMED: Stock Comparison

ALPA LABORATORIES vs THEMIS MEDICAREUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

THEMIS MEDICARE is the larger company by market capitalisation. ALPA LABORATORIES shows a lower P/E, a higher ROE and lower leverage, while THEMIS MEDICARE shows a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

ALPA leads 8; THEMISMED leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

ALPATHEMISMED

Valuation lens

What price are you paying?

Market CapContext only
₹133 Cr
₹1,124 Cr
P/E RatioALPA has the lower reading
12.09x
27.4x
P/B RatioALPA has the lower reading
0.77x
2.75x
EPSTHEMISMED has the higher reading
₹0.47
₹2.67
Book ValueContext only
₹88.53
₹43.28
Dividend YieldTHEMISMED has the higher reading
0%
0.4%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
THEMISMED is the larger company
₹1,124 Cr vs ₹133 Cr
P/E Ratio
ALPA has a lower P/E
12.09x vs 27.4x
P/B Ratio
ALPA has a lower P/B
0.77x vs 2.75x
EPS
THEMISMED has higher earnings per share
₹2.67 vs ₹0.47
Dividend Yield
THEMISMED has a higher dividend yield
0.4% vs 0%
Revenue Growth (TTM YoY)
THEMISMED has faster revenue growth
6.7% vs -21.4%
Qtr Profit Growth
ALPA has stronger quarterly profit growth
-5.6% vs -14.36%
ROE
ALPA has a higher ROE
7.58% vs -4.71%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricALPATHEMISMED
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricALPATHEMISMED
Live Price₹62.71₹120.42
Day Change-0.93%-3.56%
Volume9,1941.59 L
52-Week High₹99₹148
52-Week Low₹46.1₹64.95
Distance from 52W High-36.66%-18.64%

Valuation

MetricALPATHEMISMED
Market Cap₹133 Cr₹1,124 Cr
P/E Ratio12.09x27.4x
P/B Ratio0.77x2.75x
EPS₹0.47₹2.67
Book Value₹88.53₹43.28
Dividend Yield0%0.4%

Growth

MetricALPATHEMISMED
Revenue Growth (TTM YoY)-21.4%6.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%0%
Qtr Profit Growth-5.6%-14.36%

Profitability & Leverage

MetricALPATHEMISMED
ROE7.58%-4.71%
ROCE7.63%-0.63%
Net Margin14.33%0.33%
Operating Margin15.19%-0.79%
Debt to Equity0.01x0.33x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricALPATHEMISMED
Promoter Holding57.19%57.5%
FII Holding0.35% 0.03 pp0.01% 0.1 pp
DII Holding0.07% 0.07 pp0.01%
Public Holding42.39% 0.04 pp32.87% 0.09 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: ALPA LABORATORIES and THEMIS MEDICARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.